Cline Darren S 4
4 · Pyxis Oncology, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Cline Darren S
Director
Transactions
- Award
Stock Option (Right to buy)
2021-10-07+42,191→ 42,191 totalExercise: $16.00Exp: 2031-10-07→ Common Stock (42,191 underlying)
Footnotes (1)
- [F1]These stock options vest as to 1/3 of the shares covered by the option on each annual general meeting of the Issuer's stockholders following the October 7, 2021 grant date, subject to the reporting person's continued service through the applicable vesting date.